No Data
TONGRENTANGCM (03613.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui reported on March 13 that TONGRENTANGCM (03613.HK) announced that the company will hold a Board of Directors meeting on March 28, 2025, to consider and approve the group's annual performance for the year ending December 31, 2024, and its publication, as well as to consider the distribution of a final dividend (if any).
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
CLSA PREMIUM (06877) received a discount of approximately 33.57% from Beijing Tongrentang (Cayman) Limited for the full acquisition offer.
CLSA PREMIUM (06877) and the offeror Beijing Tongrentang (Cayman) Limited jointly announced...
[New Stock IPO] Beijing Tongrentang Medical Care Investment Co., Ltd. has submitted a listing application to the Main Board of the Hong Kong Stock Exchange.
Jingwu Finance News | According to the Hong Kong Stock Exchange's disclosure on December 31, Beijing Tongrentang Medical and Nursing Investment Co., Ltd. submitted a listing application to the Main Board of the Hong Kong Stock Exchange, with China International Capital Corporation as the exclusive sponsor. The company is a leading Traditional Chinese Medicine medical group, consisting of its own and managed medical institutions at three levels: chain hospitals, grassroots chain medical institutions (including outpatient departments, clinics, and Community health institutions, all independent medical institutions in China that Hold various types of licenses or certificates to operate), and Internet Plus-Related hospitals. Combining "medicine" and "nursing," the company provides modern and customized Traditional Chinese Medicine Medical Services, covering all scenarios with standardized management, utilizing its advantageous specialties.
Beijing Tongrentang (600085.SH) and its holding subsidiaries plan to lease properties.
On December 30, Gelonghui reported that Beijing Tongrentang (600085.SH) announced that in 2025, the company and its controlling subsidiary, Peking Tongrentang Commercial Investment Group Co., Ltd. (referred to as Tongrentang Commercial), plan to lease properties from China Peking Tongrentang (Group) Co., Ltd. (including its subsidiaries, excluding the scope of the company's consolidated financial statements, referred to as Tongrentang Group) to meet production, operation, and daily office needs, with an annual rent totaling no more than 20 million yuan; the company plans to lease properties to Tongrentang Group to enhance the operational capacity of some idle properties, with an annual rent totaling no more than 5 million yuan.
Beijing Tongrentang (600085.SH): Plans to sign a framework agreement for brand licensing with related parties.
On December 30, GELONGHUI reported that TONG REN TANG (600085.SH) announced that the "TONG REN TANG" trademark and name are owned by TONG REN TANG Group. In order to fully protect the interests of all parties, reasonably safeguard the value of state-owned Assets, and ensure the continuous and stable Operation of the company and its holding subsidiary TONG REN TANG Technology, as well as TONG REN TANG Commercial, the company and its holding subsidiaries intend to sign a "Brand License Framework Agreement" with TONG REN TANG Group, with a term of three years, agreeing that the company, TONG REN TANG Technology, TONG REN TANG Commercial, and affiliated enterprises using the "TONG REN TANG" brand (hereinafter referred to as member units) will pay TONG REN TANG Group the fees related to the use of the "TONG REN TANG" brand.